Xml Financial, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Xml Financial, LLC

$1.13 Billion
Q2 2025

A detailed history of Xml Financial, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Xml Financial, LLC holds 605 shares of REGN stock, worth $338,679. This represents 0.03% of its overall portfolio holdings.

Number of Shares

605

Previous 592 2.2%

Holding current value

$338,679

Previous $375,000 15.47%

% of portfolio

0.03%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 17, 2025	BUY	$483.07 - $625.6 $6,279 - $8,132	13 Added 2.2%	605 $317,000
Q1 2025 Apr 22, 2025	SELL	$634.14 - $744.83 $286,631 - $336,663	-452 Reduced 43.3%	592 $375,000
Q4 2024 Jan 17, 2025	SELL	$701.85 - $1046.91 $44,216 - $65,955	-63 Reduced 5.69%	1,044 $743,000
Q3 2024 Nov 01, 2024	SELL	$1024.09 - $1201.76 $102,408 - $120,176	-100 Reduced 8.29%	1,107 $1.16 Million
Q2 2024 Jul 22, 2024	SELL	$883.2 - $1071.19 $26,496 - $32,135	-30 Reduced 2.43%	1,207 $1.27 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $18,053 - $19,867	-20 Reduced 1.59%	1,237 $1.19 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $37,208 - $42,321	48 Added 3.97%	1,257 $1.1 Million
Q3 2023 Nov 06, 2023	SELL	$692.45 - $844.37 $11,079 - $13,509	-16 Reduced 1.31%	1,209 $994,000
Q2 2023 Aug 07, 2023	BUY	$700.03 - $830.35 $42,701 - $50,651	61 Added 5.24%	1,225 $880,000
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $61,244 - $74,427	-90 Reduced 7.18%	1,164 $956,000
Q4 2022 Feb 09, 2023	SELL	$705.89 - $766.39 $21,176 - $22,991	-30 Reduced 2.34%	1,254 $904,000
Q3 2022 Nov 04, 2022	BUY	$573.97 - $724.32 $29,846 - $37,664	52 Added 4.22%	1,284 $885,000
Q2 2022 Aug 01, 2022	BUY	$548.35 - $738.84 $87,736 - $118,214	160 Added 14.93%	1,232 $728,000
Q1 2022 May 02, 2022	BUY	$595.12 - $698.43 $52,965 - $62,160	89 Added 9.05%	1,072 $749,000
Q4 2021 Feb 01, 2022	SELL	$543.48 - $670.97 $10,869 - $13,419	-20 Reduced 1.99%	983 $621,000
Q3 2021 Nov 01, 2021	BUY	$574.03 - $680.96 $60,273 - $71,500	105 Added 11.69%	1,003 $607,000
Q2 2021 Aug 10, 2021	BUY	$472.8 - $558.54 $1,418 - $1,675	3 Added 0.34%	898 $502,000
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $119,723 - $146,917	268 Added 42.74%	895 $423,000
Q4 2020 Feb 08, 2021	BUY	$478.3 - $607.98 $2,391 - $3,039	5 Added 0.8%	627 $303,000
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $54,475 - $65,821	-100 Reduced 13.85%	622 $348,000
Q2 2020 Jul 31, 2020	SELL	$493.32 - $643.92 $64,624 - $84,353	-131 Reduced 15.36%	722 $450,000
Q1 2020 May 08, 2020	BUY	$336.18 - $494.43 $4,370 - $6,427	13 Added 1.55%	853 $417,000
Q4 2019 Feb 04, 2020	BUY	$274.13 - $376.51 $230,269 - $316,268	840 New	840 $315,000

Others Institutions Holding REGN

# of Institutions

1,425

Shares Held

85.2M

Call Options Held

1.39M

Put Options Held

1.42M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $60B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xml Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xml Financial, LLC with notifications on news.

Account

Xml Financial, LLC Regeneron Pharmaceuticals, Inc. Transaction History